Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice.

We previously reported that brain-derived neurotrophic factor (BDNF) regulates both food intake and blood glucose metabolism in rodent obese diabetic models such as C57BL/KsJ-lepr(db)/lepr(db) (db/db) mice. To elucidate the effect of BDNF on glucose metabolism, we designed a novel pellet pair-feeding apparatus to eliminate the effect of appetite alteration on glucose metabolism. The apparatus was used to synchronize food intake precisely between BDNF-treated and vehicle-treated db/db mice. It was shown using this pellet pair-feeding apparatus that BDNF administered daily (20 mg x kg(-1) x day(-1)) to db/db mice significantly lowered blood glucose compared with pellet pair-fed db/db mice. To evaluate the effect of BDNF on insulin action, we used streptozotocin-induced type 1 diabetic mice. In this case, BDNF did not lower blood glucose concentration but rather enhanced the hypoglycemic action of insulin. In hyperglycemic db/db mice, pancreatic insulin content was reduced and glucagon content was increased compared with normoglycemic db/m mice. BDNF administered to db/db mice significantly restored both pancreatic insulin and glucagon content. Histological observations of aldehyde-fuchsin staining and immunostaining with anti-insulin indicated that insulin-positive pancreatic beta-cells were extensively regranulated by BDNF administration. We also studied the effect of BDNF on KK mice, normoglycemic animals with impaired glucose tolerance. In these mice, BDNF administration improved insulin resistance in the oral glucose tolerance test. To elucidate how blood glucose was metabolized in BDNF-treated animals, we investigated the effect of BDNF on the energy metabolism of db/db mice. Body temperature and oxygen consumption of the pellet pair-fed vehicle-treated mice were remarkably lower than the ad libitum-fed vehicle-treated mice. Daily BDNF administration for 3 weeks completely ameliorated both of the reductions. Finally, to clarify its action mechanism, the effect of intracerebroventricular administration of BDNF on db/db mice was examined. Here, a small dose of BDNF was found to be effective in lowering blood glucose concentration. This indicates that BDNF regulates glucose metabolism by acting directly on the brain.

[1]  M. Bothwell,et al.  Novel roles for neurotrophins are suggested by BDNF and NT-3 mRNA expression in developing neurons , 1992, Neuron.

[2]  H. Koizumi,et al.  Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues. , 1996, The American journal of pathology.

[3]  G. Leveille,et al.  Core temperature, O2 consumption, and early detection of ob-ob genotype in mice. , 1974, The American journal of physiology.

[4]  康生 大久保,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study , 1995 .

[5]  R. Seeley,et al.  Identification of targets of leptin action in rat hypothalamus. , 1996, The Journal of clinical investigation.

[6]  J. Himms-Hagen,et al.  Brown adipose tissue metabolism and thermogenesis. , 1985, Annual review of nutrition.

[7]  T. Sohda,et al.  Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. , 1990, Arzneimittel-Forschung.

[8]  S. W. Ranson,et al.  THE SPONTANEOUS ACTIVITY AND FOOD INTAKE OF RATS WITH HYPOTHALAMIC LESIONS , 1942 .

[9]  P. Ernfors,et al.  Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system , 1992, Neuroscience.

[10]  J. Auwerx,et al.  Pioglitazone Induces In Vivo Adipocyte Differentiation in the Obese Zucker fa/fa Rat , 1997, Diabetes.

[11]  M. Barbacid Neurotrophic Factors and Their Receptors , 1995, Bio/Technology.

[12]  C. Saper,et al.  Leptin activates neurons in ventrobasal hypothalamus and brainstem. , 1997, Endocrinology.

[13]  M. Shichiri Symposium on treatment of diabetic complications. 5. Strict glycemic control and diabetic microvascular complications. , 1997, Internal medicine.

[14]  H. Iwatsuka,et al.  Studies on diabetogenic action of obesity in mice: congenital insulin resistance of KK mice. , 1970, Endocrinologia japonica.

[15]  Y. Barde,et al.  Regional distribution of brain‐derived neurotrophic factor mRNA in the adult mouse brain. , 1990, The EMBO journal.

[16]  S. Korsching,et al.  The neurotrophic factor concept: a reexamination , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  M. Igarashi,et al.  Thiazolidinediones (AD-4833 and CS-045) improve hepatic insulin resistance in streptozotocin-induced diabetic rats. , 1993, Endocrine journal.

[18]  Y Itakura,et al.  Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. , 1997, Biochemical and biophysical research communications.

[19]  G. Gomori Aldehyde-fuchsin: a new stain for elastic tissue. , 1950, American journal of clinical pathology.

[20]  J. Olefsky,et al.  Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects , 1992, Diabetes Care.

[21]  R. Darnell,et al.  Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Umesono,et al.  Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. , 1998, The Journal of clinical investigation.

[23]  H. Joosten,et al.  Role of the thyroid in the development of the obese-hyperglycemic syndrome in mice (ob ob). , 1974, Metabolism: clinical and experimental.

[24]  M. Dragunow,et al.  The role of neuronal growth factors in neurodegenerative disorders of the human brain , 1998, Brain Research Reviews.

[25]  W. Mobley,et al.  Therapeutic potential of neurotrophic factors for neurological disorders , 1996, Annals of neurology.

[26]  T. Fujiwara,et al.  Characterization of New Oral Antidiabetic Agent CS-045: Studies in KK and ob/ob Mice and Zucker Fatty Rats , 1988, Diabetes.

[27]  D. Holtzman,et al.  Nerve growth factor and the neurotrophic factor hypothesis , 1996, Brain and Development.

[28]  Stanley J. Wiegand,et al.  Neurotrophic factors: from molecule to man , 1994, Trends in Neurosciences.

[29]  M. Dickie,et al.  Basal oxygen consumption of hereditarily obese and diabetic mice. , 1952, Endocrinology.

[30]  M. Skup BDNF and NT-3 widen the scope of neurotrophin activity: pharmacological implications. , 1994, Acta neurobiologiae experimentalis.

[31]  Y. Barde,et al.  Physiology of the neurotrophins. , 1996, Annual review of neuroscience.

[32]  M. Barbacid The Trk family of neurotrophin receptors. , 1994, Journal of neurobiology.

[33]  W. Roesler,et al.  Age-related Changes in Hepatic Glycogen Metabolism in the Genetically Diabetic (db/db) Mouse , 1985, Diabetes.